Your browser doesn't support javascript.
loading
Chemical Cross-Linking Stabilizes Native-Like HIV-1 Envelope Glycoprotein Trimer Antigens.
Schiffner, Torben; de Val, Natalia; Russell, Rebecca A; de Taeye, Steven W; de la Peña, Alba Torrents; Ozorowski, Gabriel; Kim, Helen J; Nieusma, Travis; Brod, Florian; Cupo, Albert; Sanders, Rogier W; Moore, John P; Ward, Andrew B; Sattentau, Quentin J.
Afiliação
  • Schiffner T; The Sir William Dunn School of Pathology, The University of Oxford, Oxford, United Kingdom.
  • de Val N; Department of Integrative Structural and Computational Biology, IAVI Neutralizing Antibody Center, Collaboration for AIDS Vaccine Discovery, and Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, La Jolla, California, USA.
  • Russell RA; The Sir William Dunn School of Pathology, The University of Oxford, Oxford, United Kingdom.
  • de Taeye SW; Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • de la Peña AT; Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Ozorowski G; Department of Integrative Structural and Computational Biology, IAVI Neutralizing Antibody Center, Collaboration for AIDS Vaccine Discovery, and Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, La Jolla, California, USA.
  • Kim HJ; Department of Integrative Structural and Computational Biology, IAVI Neutralizing Antibody Center, Collaboration for AIDS Vaccine Discovery, and Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, La Jolla, California, USA.
  • Nieusma T; Department of Integrative Structural and Computational Biology, IAVI Neutralizing Antibody Center, Collaboration for AIDS Vaccine Discovery, and Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, La Jolla, California, USA.
  • Brod F; The Sir William Dunn School of Pathology, The University of Oxford, Oxford, United Kingdom.
  • Cupo A; Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, New York, USA.
  • Sanders RW; Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, New York, USA.
  • Moore JP; Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, New York, USA.
  • Ward AB; Department of Integrative Structural and Computational Biology, IAVI Neutralizing Antibody Center, Collaboration for AIDS Vaccine Discovery, and Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, The Scripps Research Institute, La Jolla, California, USA.
  • Sattentau QJ; The Sir William Dunn School of Pathology, The University of Oxford, Oxford, United Kingdom quentin.sattentau@path.ox.ac.uk.
J Virol ; 90(2): 813-28, 2016 01 15.
Article em En | MEDLINE | ID: mdl-26512083
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígenos HIV / HIV-1 / Produtos do Gene env do Vírus da Imunodeficiência Humana Limite: Humans Idioma: En Revista: J Virol Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígenos HIV / HIV-1 / Produtos do Gene env do Vírus da Imunodeficiência Humana Limite: Humans Idioma: En Revista: J Virol Ano de publicação: 2016 Tipo de documento: Article